Skip to main content

Table 11 Comparison of different dose exposures

From: Application of the HTA Core Model for complex evaluation of the effectiveness and quality of Radium-223 treatment in patients with metastatic castration resistant prostate cancer

Comparison of different dose exposures in ÎĽSv/h

in the distance

1 m from the patient

2 m from the patient

3 h after application of Technetium-99 m-labeled pharmaceuticals used in the skeletal scintigraphy

5.4–13.4

not measured

30 min after Radium-223 application

0.376–0.504

0.183–0.205

background in corridors and offices

0.101–0.141

  1. μSv/h – microsievert/hour
  2. Source: Own processing